151 related articles for article (PubMed ID: 20602420)
1. Green preparation process, characterization and antitumor effects of doxorubicin-BSA-dextran nanoparticles.
Deng W; Li J; Yao P; He F; Huang C
Macromol Biosci; 2010 Oct; 10(10):1224-34. PubMed ID: 20602420
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticles with dextran/chitosan shell and BSA/chitosan core--doxorubicin loading and delivery.
Qi J; Yao P; He F; Yu C; Huang C
Int J Pharm; 2010 Jun; 393(1-2):176-84. PubMed ID: 20381598
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface.
Hao H; Ma Q; Huang C; He F; Yao P
Int J Pharm; 2013 Feb; 444(1-2):77-84. PubMed ID: 23370437
[TBL] [Abstract][Full Text] [Related]
4. Self-assembly of ibuprofen and bovine serum albumin-dextran conjugates leading to effective loading of the drug.
Li J; Yao P
Langmuir; 2009 Jun; 25(11):6385-91. PubMed ID: 19371045
[TBL] [Abstract][Full Text] [Related]
5. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells.
Li YL; Zhu L; Liu Z; Cheng R; Meng F; Cui JH; Ji SJ; Zhong Z
Angew Chem Int Ed Engl; 2009; 48(52):9914-8. PubMed ID: 19937876
[No Abstract] [Full Text] [Related]
6. Heat-treated emulsions with cross-linking bovine serum albumin interfacial films and different dextran surfaces: effect of paclitaxel delivery.
Qi J; Huang C; He F; Yao P
J Pharm Sci; 2013 Apr; 102(4):1307-17. PubMed ID: 23389967
[TBL] [Abstract][Full Text] [Related]
7. Fabrication of rectorite-contained nanoparticles for drug delivery with a green and one-step synthesis method.
Tu H; Lu Y; Wu Y; Tian J; Zhan Y; Zeng Z; Deng H; Jiang L
Int J Pharm; 2015 Sep; 493(1-2):426-33. PubMed ID: 26231105
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
[TBL] [Abstract][Full Text] [Related]
9. Probing Conformational Change of Bovine Serum Albumin-Dextran Conjugates under Controlled Dry Heating.
Xia S; Li Y; Zhao Q; Li J; Xia Q; Zhang X; Huang Q
J Agric Food Chem; 2015 Apr; 63(16):4080-6. PubMed ID: 25871527
[TBL] [Abstract][Full Text] [Related]
10. In situ preparation of gold nanoparticle-loaded lysozyme-dextran nanogels and applications for cell imaging and drug delivery.
Cai H; Yao P
Nanoscale; 2013 Apr; 5(7):2892-900. PubMed ID: 23447082
[TBL] [Abstract][Full Text] [Related]
11. Lysozyme-dextran core-shell nanogels prepared via a green process.
Li J; Yu S; Yao P; Jiang M
Langmuir; 2008 Apr; 24(7):3486-92. PubMed ID: 18302424
[TBL] [Abstract][Full Text] [Related]
12. Smart and dual-targeted BSA nanomedicine with controllable release by high autolysosome levels.
Zhang Z; Dong C; Yu G; Cheng W; Liang Y; Pan Y; Li H; Ji H
Colloids Surf B Biointerfaces; 2019 Oct; 182():110325. PubMed ID: 31301582
[TBL] [Abstract][Full Text] [Related]
13. Molecular characteristics of bovine serum albumin-dextran conjugates.
Jung SH; Choi SJ; Kim HJ; Moon TW
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2064-70. PubMed ID: 16960356
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization novel polymer-coated magnetic nanoparticles as carriers for doxorubicin.
Li F; Sun J; Zhu H; Wen X; Lin C; Shi D
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):58-62. PubMed ID: 21764271
[TBL] [Abstract][Full Text] [Related]
15. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
16. Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles.
Alhareth K; Vauthier C; Bourasset F; Gueutin C; Ponchel G; Moussa F
Eur J Pharm Biopharm; 2012 Jun; 81(2):453-7. PubMed ID: 22465096
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and Fe
Hao H; Ma Q; He F; Yao P
J Mater Chem B; 2014 Dec; 2(45):7978-7987. PubMed ID: 32262088
[TBL] [Abstract][Full Text] [Related]
18. Single-phased luminescent mesoporous nanoparticles for simultaneous cell imaging and anticancer drug delivery.
Di W; Ren X; Zhao H; Shirahata N; Sakka Y; Qin W
Biomaterials; 2011 Oct; 32(29):7226-33. PubMed ID: 21745687
[TBL] [Abstract][Full Text] [Related]
19. Optimization of preparation and property studies on glycosylated albumin as drug carrier for nanoparticles.
Gao Y; Sun W; Zhang J
Pharmazie; 2011 Jul; 66(7):484-90. PubMed ID: 21812322
[TBL] [Abstract][Full Text] [Related]
20. A facile approach for crosslinker free nano self assembly of protein for anti-tumor drug delivery: factors' optimization, characterization and in vitro evaluation.
Asghar S; Salmani JM; Hassan W; Xie Y; Meng F; Su Z; Sun M; Xiao Y; Ping Q
Eur J Pharm Sci; 2014 Oct; 63():53-62. PubMed ID: 25004412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
